Johns Hopkins Digital Twin Hearts Achieve 100% Arrhythmia-Free Rate in First FDA-Approved Clinical Trial
The TWIN-VT trial used personalized computational heart models to guide ventricular tachycardia ablation, with all 10 patients remaining arrhythmia-free after more than a year.
3 min read3 sources